Skip to main content Accessibility help
×
Home

Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors

  • Heather J. Adam (a1), Vanessa G. Allen (a1), Andrea Currie (a2), Allison J. McGeer (a1) (a3), Andrew E. Simor (a1) (a4), Susan E. Richardson (a1) (a5), Lisa Louie (a4), Barbara Willey (a3), Tim Rutledge (a2), Jacques Lee (a4), Ran D. Goldman (a6), Andrea Somers (a7), Paul Ellis (a7), Alicia Sarabia (a8), John Rizos (a8), Bjug Borgundvaag (a3), Kevin C. Katz (a1) (a2) (a9) and EMERGENT Working Group...

Abstract

Objective:

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), which is caused primarily by the Canadian methicillin-resistant Staphylococcus aureus-10 (CMRSA-10) strain (also known as the USA300 strain) has emerged rapidly in the United States and is now emerging in Canada. We assessed the prevalence, risk factors, microbiological characteristics and outcomes of CA-MRSA in patients with purulent skin and soft tissue infections (SSTIs) presenting to emergency departments (EDs) in the Greater Toronto Area.

Methods:

Patients with Staphylococcus aureus SSTIs who presented to 7 EDs between Mar. 1 and Jun. 30, 2007, were eligible for inclusion in this study. Antimicrobial susceptibilities and molecular characteristics of MRSA strains were identified. Demographic, risk factor and clinical data were collected through telephone interviews.

Results:

MRSA was isolated from 58 (19%) of 299 eligible patients. CMRSA-10 was identified at 6 of the 7 study sites and accounted for 29 (50%) of all cases of MRSA. Telephone interviews were completed for 161 of the eligible patients. Individuals with CMRSA-10 were younger (median 34 v. 63 yr, p = 0.002), less likely to report recent antibiotic use (22% v. 67%, p = 0.046) or health care–related risk factors (33% v. 72%, p = 0.097) and more likely to report community-related risk factors (56% v. 6%, p = 0.008) than patients with other MRSA strains. CMRSA-10 SSTIs were treated with incision and drainage (1 patient), antibiotic therapy (3 patients) or both (5 patients), and all resolved. CMRSA-10 isolates were susceptible to clindamycin, tetracycline and trimethoprimsulfamethoxazole.

Conclusion:

CA-MRSA is a significant cause of SSTIs in the Greater Toronto Area, and can affect patients without known community-related risk factors. The changing epidemiology of CA-MRSA necessitates further surveillance to inform prevention strategies and empiric treatment guidelines.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors
      Available formats
      ×

Copyright

Corresponding author

Department of Laboratory Medicine, North York General Hospital, Toronto ON M2K 1E1; kkatz@nygh.on.ca

References

Hide All
1.Barton, M, Hawkes, M, Moore, D, et al Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA): a perspective for Canadian health care practitioners. Can J Infect Dis Med Micro 2006;17(Suppl C):1B–24B.
2.Gilbert, M, MacDonald, J, Gregson, D, et al Outbreak in alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006;175:149–54.
3.Groom, AV, Wolsey, DH, Naimi, TS, et al Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286:1201–5.
4.Kaplan, SL, Hulten, K, Gonzalez, B, et al Three-year surveillance of community-acquired Staphylococus aureus infections in children. Clin Infect Dis 2005;40:1785–91.
5Kazakova, S, Hageman, J, Matava, M, et al A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468–75.
6.Lee, NE, Taylor, MM, Bancroft, E, et al Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005;40:1529–34.
7.Main, CL, Jayarante, P, Haley, A, et al Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol 2005;16:343–8.
8.Mathews, WC, Caperna, J, Barber, R, et al Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;40:155–60.
9.Rosenthal, A, White, D, Churilla, S, et al Optimal surveillance culture sites for detection of methicillin-resistant Staphylococcus aureus in newborns. J Clin Microbiol 2006;44:4234–6.
10.Zinderman, CE, Conner, B, Malakooti, MA, et al Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis 2004;10:941–4.
11.Ruhe, J, Smith, N, Menon, A, et al Significance of antibiotic therapy for the treatment of community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections. Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 September 27–30; San Francisco (CA): American Society for Microbiology.
12.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et al Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.
13.Weese, JS, Rousseau, J, Willey, B, et al Methicillin-resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease. J Vet Intern Med 2006;20:182–6.
14.Kurbis, C, Wylie, J. Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis 2001;12:149–52.
15.McGeer, A, Fleming, C, Green, K, et al Antimicrobial resistance in common hospital pathogens in Ontario. QMPLS News 2007;116:112.
16.Surveillance for methicillin-resistant Staphylococcus aureus (MRSA) 2006 Results. Ottawa (ON): Canadian Nosocomial Infection Surveillance Program (CNISP); 2006. Available: www.phac-aspc.gc.ca/nois-sinp/projects/pdf/mrsa_report2006-eng.pdf (accessed 2009 July 28).
17.Naimi, TS, LeDell, KH, Como-Sabetti, K, et al Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976–84.
18.Labandeira-Rey, M, Couzon, F, Boisset, S, et al Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007;315:1130–3.
19.Popovich, K, Hota, B, Rice, T, et al Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007;45:2293–5.
20.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 17th informational supplement. m100-s17. Wayne (PA): The Institute; 2007.
21.Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A7. Wayne (PA): The Institute; 2006.
22.Fuchs, PC, Jones, RN, Barry, AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990;28:608–9.
23.Toma, E, Barriault, D. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci. J Clin Microbiol 1995;33:1712–5.
24.Mulvey, MR, Chui, L, Ismail, J, et al Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol 2001;39:3481–5.
25.Lina, G, Piemont, Y, Godail-Gamot, F, et al Involvement of panton-valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128–32.
26.Oliveira, DC, de Lencastre, H. Multiplex PCR strategy for rapid identification of structural types and variants of the MEC element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002;46:2155–61.
27.Willey, B, Wong, H, Louie, L, et al Editors. Comparison of two strategies for staphylococcal cassette chromosome mec (sccmec) typing in methicillin-resistant Staphylococcus aureus. San Francisco, (CA): 46th Interscience Conference on Antimi-crobial Agents and Chemotherapy; 2006 September 27-30.
28.Seybold, U, Kourbatova, EV, Johnson, JG, et al Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647–56.
29.Lee, MC, Rios, AM, Aten, MF, et al Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7.
30.Rajendran, PM, Young, D, Maurer, T, et al Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51:4044–8.
31.Diep, BA, Chambers, HF, Graber, CJ, et al Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249–57.
32.Talan, DA, Moran, GJ, Mower, WR, et al Emergency ID net: an emergency department-based emerging infections sentinel network. The emergency ID net study group. Ann Emerg Med 1998;32:703–11.
33.Mulvey, MR, MacDougall, L, Cholin, B, et al Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005;11:844–50.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed